Neurofeedback Training as Adjuvant Therapy for Improving Depressive Symptoms Based on Patient Health Questionnaire – 9 (Phq-9) Scores in Post schizophrenia Depression: A Case Report

Main Article Content

Ristina Ardiyani
RS Lestari Raharja
Santi Yuliani
RS Jiwa Soerojo

Post-schizophrenic depression, a depressive episode that occurs in patients with schizophrenia, often presents with more prominent depressive symptoms than schizophrenic symptoms. Despite pharmacotherapy, additional therapies are essential to improve symptoms and overall functioning. This study explores the use of neurofeedback as an adjuvant therapy in a 50-year-old female patient with a history of paranoid schizophrenia. The patient presented with symptoms of sadness, withdrawal, auditory and visual hallucinations, and a PHQ-9 score of 22. Along with pharmacotherapy (escitalopram, risperidone, and trihexyphenidyl), the patient underwent five sessions of neurofeedback with an alpha/theta/beta2 protocol aimed at enhancing alpha waves, which are often deficient in depressed individuals. Results showed that the patient's alpha wave amplitude increased from 9.2% in the first session to 9.9% in the fifth session, and the PHQ-9 score decreased, indicating improvement in depressive symptoms. These findings suggest that neurofeedback is an effective non-invasive therapy for post-schizophrenic depression, enhancing treatment outcomes when used alongside pharmacological interventions, ultimately improving the patient's quality of life and mental health.


Keywords: Neurofeedback, post-schizophrenic depression, depressive symptoms, alpha wave, Patient Health Questionnaire – 9 (PHQ-9).
Al-Qaysi, Z. T., Ahmed, M. A., Hammash, N. M., Hussein, A. F., Albahri, A. S., Suzani, M. S., Al-Bander, B., Shuwandy, M. L., & Salih, M. M. (2021). Systematic review of training environments with motor imagery brain–computer interface: coherent taxonomy, open issues and recommendation pathway solution. Health and Technology, 11(4), 783–801.
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., Text Revision; DSM-5-TR). American Psychiatric Publishing.
Demos, J. N. (2019). Getting started with EEG neurofeedback (2nd ed.). W.W. Norton & Company.
Elvira, A. D., & Hadisukantanto, G. (2022). Psychiatry textbook (3rd ed.). University of Indonesia Publishing.
Grosselin, F., Breton, A., Cherif, L. Y., Wang, X., Spinelli, G., Hugueville, L., et al. (2021). Alpha activity neuromodulation induced by individual alpha-based neurofeedback learning in ecological context: A double-blind randomized study. Journal of Neural Engineering, 18(4), 046063.
Hafeez, Y., Ali, S. S. A., Hasan, R. A., Adil, S. H., Moinuddin, M., Ebrahim, M., Yusoff, M. S. B., & Saggaf, U. A. (2021). Development of enhanced stimulus content to improve the treatment efficacy of EEG-based frontal alpha asymmetry neurofeedback for stress mitigation. Sensors, 21(20), 6844.
Liu, X., Zhang, H., Cui, Y., Zhao, T., Wang, B., Xie, X., Liang, S., et al. (2024). EEG-based major depressive disorder recognition by neural oscillation and asymmetry. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 32, 1821-1830.
Malik, K., Widyanta, E. A., Noor, I. M., Yuliani, S., Hidayanto, T., Dewi, S. Y., et al. (2025). Technical manual of psychiatric electrophysiology (2nd ed.). PDSKJI.
Markiewicz, R., Gospodarek, M. A., Dobrowolska, B., & Loza, B. (2021). Improving clinical, cognitive, and psychosocial dysfunctions in patients with schizophrenia: A neurofeedback randomized control trial. Frontiers in Psychiatry, 12, 660032.
Misaki, M., Young, K. D., Tsuchiyagaito, A., Savitz, J., & Guinjoan, S. M. (2025). Clinical response to neurofeedback in major depression relates to subtypes of whole-brain activation patterns during training. Molecular Psychiatry, 30(6), 2707-2717.
Morimoto, T., & Nakazato, Y. (2021). Reduction of depressive symptoms following alpha neurofeedback training: A pilot study using PHQ-9. Journal of Affective Disorders Reports, 5, 100136.
Negeri, F. Z., Levis, B., Sun, Y., He, C., Krishnan, A., Wu, Y., et al. (2021). Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: Updated systematic review and individual participant data meta-analysis. BMJ, 375, n2183.
Patil, A. U., Lin, C., Lee, S. H., Huang, H. W., Wu, S. C., Madathil, D., & Huang, C. M. (2023). Review of EEG-based neurofeedback as a therapeutic intervention to treat depression. Psychiatry Research: Neuroimaging, 329, 111591.
Peeters, F., Ronner, J., van Os, J., Lousberg, R., & Nicolson, N. A. (2020). Validation of the PHQ-9 as a monitoring tool for depression severity during neurofeedback treatment. Journal of Psychiatric Research, 127, 12-18.
Sadock, B. J., Ahmad, S., & Sadock, V. A. (2024). Clinical psychiatry book (6th ed.). EGC.
Xie, Y. H., Zhang, Y. M., Fan, F. F., Song, X. Y., & Liu, L. (2023). Functional role of frontal electroencephalogram alpha asymmetry in the resting state in patients with depression: A review. Frontiers in Psychiatry, 14, 1181691.
Xu, Y., Long, X., Feng, J., & Gong, P. (2023). Interacting spiral wave patterns underlie complex brain dynamics and are related to cognitive processing. Nature human behaviour, 7(7), 1196–1215.